Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Table 2 from Immunotherapy Inhibits Tumor Cholesterol Synthesis via the IFNγ–IRF1–SREBF2 Axis
  1. Home
  2. Publications
  3. Supplementary Table 2 from Immunotherapy Inhibits Tumor Cholesterol Synthesis via the IFNγ–IRF1–SREBF2 Axis

Supplementary Table 2 from Immunotherapy Inhibits Tumor Cholesterol Synthesis via the IFNγ–IRF1–SREBF2 Axis

Authors:
  • LXLiping Xu
    Liping Xu
  • XZXiaomin Zhang
    Xiaomin Zhang
  • XLXiaowei Lai
    Xiaowei Lai
  • HCHongyuan Chen
    Hongyuan Chen
  • SLShuangye Liao
    Shuangye Liao
  • MCMingzeng Chang
    Mingzeng Chang
  • XWXiaoqing Wu
    Xiaoqing Wu
  • WRWen Rui
    Wen Rui
  • JYJuan Yang
    Juan Yang
  • DWDanyang Wang
    Danyang Wang
  • CGChengqi Gao
    Chengqi Gao
  • ZFZiqian Fang
    Ziqian Fang

Open Access
Publisher website
Google Scholar
  • 4 March 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/2326-6066.31484219
Abstract
Supplementary Table 2. The independent replicates of Figure 1K
Keywords
  • SUPPLEMENTARY TABLE
  • AXIS SUPPLEMENTARY
  • IMMUNOTHERAPY INHIBITS
  • INHIBITS TUMOR
  • TUMOR CHOLESTEROL
  • CHOLESTEROL SYNTHESIS
  • TABLE
  • AXIS
  • SUPPLEMENTARY
  • IMMUNOTHERAPY
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.